|Day Low/High||143.05 / 146.68|
|52 Wk Low/High||134.25 / 178.86|
President Trump delivered a highly-anticipated speech on lowering the cost of drugs for Americans on Friday afternoon.
It has been yet another long week on Wall Street. On Friday, investors are greeted with a mild Nvidia earnings related selloff. Be on the lookout for valuation-based tech stock downgrades in the week ahead.
Since taking office, President Trump has talked big on reining in drug prices, but the administration's lack of action leaves most expecting a May 11 speech that tastes like a nothing burger.
A study of analyst recommendations at the major brokerages shows that McKesson Corp is the #44 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.
One drug distribution executive appearing before a House Committee to answer for shipping millions of doses of opioids into West Virginia apologized and another said his company had a hand in the crisis.
Cardinal Health had its worst day of trading in 14 years.
Global stocks kicked-off the week in a bullish mood Monday, with merger activity and a robust U.S. corporate earnings season helping boost markets in Europe and Asia and set up Wall Street for a positive start to the final trading day of the month.
An internal review of management behavior at the healthcare company over opioid distribution prompted by complaints from shareholder International Brotherhood of Teamsters gives company officials a clean bill of health.
Doubleline's Gundlach Launches Facebook Short Campaign, Greenlight's Einhorn believes Assured Guarantee has massive losses "baked in" while Bill Ackman Protégé Scott Ferguson eyes a break up of Britain's WhitBread plc.
A House committee trying to understand how the opioid crisis came to be and what to do next has set a May 8 hearing for drug distributors to explain their role.
While more than half the states in the U.S. have passed time limits on opioid prescription as a way to battle the epidemic, the AMA says that should be left up to the doctor and patient.
McKesson and other drug distributors are having a difficult time steering clear of controversy, with the latest blow a lawsuit alleging McKesson has violated the False Claims Act.
Amid the decline there were some winners including Red Hat and McCormick. Twitter gets a new short-seller and more activist action at United Technologies, dot a busy Tuesday. Here's what you may have missed.
President Trump made a long-awaited announcement of his administration's opioid plan in a New Hampshire speech that was part policy roll out and part political rally.
A study published by the Journal of the American Medical Association shows OTC drugs were more effective in cutting pain for chronic back pain and osteoarthritis hip and knee patients than opioids.
After months of inaction by the federal government on the crisis regarding opioid abuse, Attorney General Jeff Sessions announced the creation of a task force charged with looking at how drug makers and distributors operate.
McKesson Corporation (NYSE: MCK) (the "Company") today announced the determination of the Full Tender Offer Consideration, as shown in the table below, for its previously announced cash tender offer to purchase up to...
A study of analyst recommendations at the major brokerages shows that McKesson Corp is the #33 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.
McKesson Corporation (NYSE: MCK) (the "Company") today announced the early tender results as of the Early Tender Time (as defined below) in connection with its previously announced cash tender offer to purchase up to...
McKesson and Cardinal Health are alleged to have sent more than 12 million opioid doses to a single pharmacy in West Virginia over an eight-year period, according to a House committee probe.
In the last two weeks alone, three sectors have gotten hammered on announcements or reports about Amazon's plans.
As lawsuits tied to the opioid crisis keep piling up, Purdue Pharma is discontinuing direct sales calls to doctors. Will other opioid makers follow suit?
The White House Council of Economic Advisers on Friday, Feb. 9, released a report on how the government can help bring down drug prices.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.